News Releases

Speeches

February 5, 2008 CGPA Pharmacovigilance Working Group to the House of Commons Standing Committee on Health Study on Post-Market Surveillance Study on Post-Market Surveillance
April 23, 2007 Presentation by Apotex President and COO Jack Kay to the House of Commons Standing Committee on Industry, Science and Technology The Apotex Experience with Canada’s Access to Medicines Regime
April 23, 2007 Presentation by CGPA President Jim Keon to the House of Commons Standing Committee on Industry, Science and Technology Review of Canadian Access to Medicines Regime
June 1, 2006 Presentation by CGPA President Jim Keon to the Economic Club of Toronto Bill 102: Ontario’s Prescription for Drug Cost Savings and Greater Transparency